c-Fos is required for TGFβ1 production and the associated paracrine migratory effects of human colon carcinoma cells

Guangming Liu, Wei Ding, Xin Liu, Kathleen Mulder

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

In tumor cells that have lost responsiveness to the growth inhibitory effects of transforming growth factor β (TGFβ), increased TGFβ production by the tumor cells often contributes to cancer progression, primarily through paracrine mechanisms. Here we investigated the major components of the activator protein-1 (AP-1) complex in the TGFβ1 promoter of human colon carcinoma cells (HCCCs). In contrast to untransformed epithelial cells (UECs), HCCCs displayed constitutive activation of AP-1 at the proximal AP-1 site in the human TGFβ1 promoter. Further, in contrast to the JunD and Fra-2 components present in the AP-1 complex at this AP-1 site in UECs, c-Fos was the major detectable AP-1 component in HCCCs. Thus, transcriptional factor switching had occurred in HCCCs relative to the UECs, with regard to the proximal AP-1 site of the human TGFβ1 promoter. Small interfering RNAs (siRNAs) against c-Fos significantly suppressed AP-1 activity at the relevant AP-1 site, and led to a decrease in TGFβ1 secretion by the HCCCs. Our results indicate for the first time that c-Fos binding at the TGFβ1 promoter proximal AP-1 site in HCCCs is required for TGFβ1 production by the tumor cells. Further, we demonstrated that blockade of TGFβ1 secretion by c-Fos siRNA led to a suppression of the cellular migration and mitogenesis of NIH 3T3 fibroblasts in a paracrine fashion. Thus, c-Fos may have utility as a target for blocking tumor cell-secreted TGFβ1, thereby suppressing the migratory behavior associated with the malignant phenotype of HCCCs.

Original languageEnglish (US)
Pages (from-to)582-593
Number of pages12
JournalMolecular Carcinogenesis
Volume45
Issue number8
DOIs
StatePublished - Aug 1 2006

Fingerprint

Transcription Factor AP-1
Colon
Carcinoma
Epithelial Cells
Transforming Growth Factors
Neoplasms
Small Interfering RNA
Fibroblasts
Phenotype

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cancer Research

Cite this

@article{dc244b76f6714d5da27e86767433ec4d,
title = "c-Fos is required for TGFβ1 production and the associated paracrine migratory effects of human colon carcinoma cells",
abstract = "In tumor cells that have lost responsiveness to the growth inhibitory effects of transforming growth factor β (TGFβ), increased TGFβ production by the tumor cells often contributes to cancer progression, primarily through paracrine mechanisms. Here we investigated the major components of the activator protein-1 (AP-1) complex in the TGFβ1 promoter of human colon carcinoma cells (HCCCs). In contrast to untransformed epithelial cells (UECs), HCCCs displayed constitutive activation of AP-1 at the proximal AP-1 site in the human TGFβ1 promoter. Further, in contrast to the JunD and Fra-2 components present in the AP-1 complex at this AP-1 site in UECs, c-Fos was the major detectable AP-1 component in HCCCs. Thus, transcriptional factor switching had occurred in HCCCs relative to the UECs, with regard to the proximal AP-1 site of the human TGFβ1 promoter. Small interfering RNAs (siRNAs) against c-Fos significantly suppressed AP-1 activity at the relevant AP-1 site, and led to a decrease in TGFβ1 secretion by the HCCCs. Our results indicate for the first time that c-Fos binding at the TGFβ1 promoter proximal AP-1 site in HCCCs is required for TGFβ1 production by the tumor cells. Further, we demonstrated that blockade of TGFβ1 secretion by c-Fos siRNA led to a suppression of the cellular migration and mitogenesis of NIH 3T3 fibroblasts in a paracrine fashion. Thus, c-Fos may have utility as a target for blocking tumor cell-secreted TGFβ1, thereby suppressing the migratory behavior associated with the malignant phenotype of HCCCs.",
author = "Guangming Liu and Wei Ding and Xin Liu and Kathleen Mulder",
year = "2006",
month = "8",
day = "1",
doi = "10.1002/mc.20189",
language = "English (US)",
volume = "45",
pages = "582--593",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "8",

}

c-Fos is required for TGFβ1 production and the associated paracrine migratory effects of human colon carcinoma cells. / Liu, Guangming; Ding, Wei; Liu, Xin; Mulder, Kathleen.

In: Molecular Carcinogenesis, Vol. 45, No. 8, 01.08.2006, p. 582-593.

Research output: Contribution to journalArticle

TY - JOUR

T1 - c-Fos is required for TGFβ1 production and the associated paracrine migratory effects of human colon carcinoma cells

AU - Liu, Guangming

AU - Ding, Wei

AU - Liu, Xin

AU - Mulder, Kathleen

PY - 2006/8/1

Y1 - 2006/8/1

N2 - In tumor cells that have lost responsiveness to the growth inhibitory effects of transforming growth factor β (TGFβ), increased TGFβ production by the tumor cells often contributes to cancer progression, primarily through paracrine mechanisms. Here we investigated the major components of the activator protein-1 (AP-1) complex in the TGFβ1 promoter of human colon carcinoma cells (HCCCs). In contrast to untransformed epithelial cells (UECs), HCCCs displayed constitutive activation of AP-1 at the proximal AP-1 site in the human TGFβ1 promoter. Further, in contrast to the JunD and Fra-2 components present in the AP-1 complex at this AP-1 site in UECs, c-Fos was the major detectable AP-1 component in HCCCs. Thus, transcriptional factor switching had occurred in HCCCs relative to the UECs, with regard to the proximal AP-1 site of the human TGFβ1 promoter. Small interfering RNAs (siRNAs) against c-Fos significantly suppressed AP-1 activity at the relevant AP-1 site, and led to a decrease in TGFβ1 secretion by the HCCCs. Our results indicate for the first time that c-Fos binding at the TGFβ1 promoter proximal AP-1 site in HCCCs is required for TGFβ1 production by the tumor cells. Further, we demonstrated that blockade of TGFβ1 secretion by c-Fos siRNA led to a suppression of the cellular migration and mitogenesis of NIH 3T3 fibroblasts in a paracrine fashion. Thus, c-Fos may have utility as a target for blocking tumor cell-secreted TGFβ1, thereby suppressing the migratory behavior associated with the malignant phenotype of HCCCs.

AB - In tumor cells that have lost responsiveness to the growth inhibitory effects of transforming growth factor β (TGFβ), increased TGFβ production by the tumor cells often contributes to cancer progression, primarily through paracrine mechanisms. Here we investigated the major components of the activator protein-1 (AP-1) complex in the TGFβ1 promoter of human colon carcinoma cells (HCCCs). In contrast to untransformed epithelial cells (UECs), HCCCs displayed constitutive activation of AP-1 at the proximal AP-1 site in the human TGFβ1 promoter. Further, in contrast to the JunD and Fra-2 components present in the AP-1 complex at this AP-1 site in UECs, c-Fos was the major detectable AP-1 component in HCCCs. Thus, transcriptional factor switching had occurred in HCCCs relative to the UECs, with regard to the proximal AP-1 site of the human TGFβ1 promoter. Small interfering RNAs (siRNAs) against c-Fos significantly suppressed AP-1 activity at the relevant AP-1 site, and led to a decrease in TGFβ1 secretion by the HCCCs. Our results indicate for the first time that c-Fos binding at the TGFβ1 promoter proximal AP-1 site in HCCCs is required for TGFβ1 production by the tumor cells. Further, we demonstrated that blockade of TGFβ1 secretion by c-Fos siRNA led to a suppression of the cellular migration and mitogenesis of NIH 3T3 fibroblasts in a paracrine fashion. Thus, c-Fos may have utility as a target for blocking tumor cell-secreted TGFβ1, thereby suppressing the migratory behavior associated with the malignant phenotype of HCCCs.

UR - http://www.scopus.com/inward/record.url?scp=33746999958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746999958&partnerID=8YFLogxK

U2 - 10.1002/mc.20189

DO - 10.1002/mc.20189

M3 - Article

C2 - 16637060

AN - SCOPUS:33746999958

VL - 45

SP - 582

EP - 593

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 8

ER -